Skip to main content
Top

Inflammation

Issue 2/2011

Content (8 Articles)

White Blood Cell Subtypes after STEMI: Temporal Evolution, Association with Cardiovascular Magnetic Resonance—Derived Infarct Size and Impact on Outcome

Oliver Husser, Vicente Bodi, Juan Sanchis, Julio Nunez, Luis Mainar, Francisco Javier Chorro, Maria Pilar Lopez-Lereu, Jose Vicente Monmeneu, Fabian Chaustre, Maria J. Forteza, Isabel Trapero, Francisco Dasi, Isabel Benet, Günter A. J. Riegger, Angel Llacer

Calgranulin B (S100A9/MRP14): A Key Molecule in Idiopathic Pulmonary Fibrosis?

Elena Bargagli, Carmela Olivieri, Marcella Cintorino, Rosa M. Refini, Nicola Bianchi, Antje Prasse, Paola Rottoli

Phagocytotic Competence of Differentiated U937 Cells for Colloidal Drug Delivery Systems in Immune Cells

Jacqueline Leßig, Björn Neu, Hans-Jürgen Glander, Jürgen Arnhold, Uta Reibetanz

Cryptotanshinone Suppressed Inflammatory Cytokines Secretion in RAW264.7 Macrophages through Inhibition of the NF-κB and MAPK Signaling Pathways

Shu Tang, Xiao-Yan Shen, He-Qing Huang, Suo-Wen Xu, Yang Yu, Chang-Hua Zhou, Shao-Rui Chen, Kang Le, Yu-Hua Wang, Pei-Qing Liu

Porphyromonas gingivalis Induces RANKL in T-cells

Georgios N. Belibasakis, Durga Reddi, Nagihan Bostanci

High-Carbohydrate Diet Selectively Induces Tumor Necrosis Factor-α Production in Mice Liver

Adaliene Versiani Matos Ferreira, Érica Guilhen Mario, Laura Cristina Jardim Porto, Silvia Passos Andrade, Leida Maria Botion

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine